華軟科技:子公司擬開展生產及銷售醫用口罩、醫用防護服、消毒酒精等業務
格隆匯2月10日丨華軟科技(002453.SZ)公佈,當前新型冠狀病毒肺炎疫情防控進入關鍵期,為應對醫療防護物資短缺的局面,公司積極履行上市公司社會責任,貫徹落實國務院及地方政府關於全力加快疫情防控物資生產的部署,公司之控股子公司福建省力菲克藥業有限公司(“力菲克藥業”)基於落實當地政府要求,迅速應對疫情所需,解決部分醫療防護物資供應不足問題,擬開展生產及銷售醫用口罩、醫用防護服、消毒酒精等業務。擬生產部分醫療防護物資情況如下:
1、醫用口罩業務
力菲克藥業將利用原有10萬級潔淨車間轉產醫用口罩,現已採購5條口罩(一次性使用醫用口罩、醫用外科口罩、醫用防護口罩)生產線,設備將陸續運抵生產基地並在安裝調試合格後投入生產,預計本月底前陸續形成產能。滿負荷生產後一次性使用醫用口罩、醫用外科口罩產能合計約為40萬片/日,醫用防護口罩(符合N95標準)產能約5萬片/日。力菲克藥業將在醫用口罩產品和生產線取得產品註冊和生產許可後開展生產。
2、醫用防護服業務
力菲克藥業將利用現有10萬級潔淨車間生產醫用防護服,現已購入醫用防護服生產設備,近期將試生產,滿負荷生產後產能約為3000件/日。力菲克藥業將在醫用防護服產品和生產線取得產品註冊和生產許可後開展生產。
同時,力菲克藥業也將開展消毒酒精的生產。
在政府部門的支持和幫助下,公司將積極行動,保質、保量生產防控疫情急需醫療防護產品,全力以赴做好疫情防控相關工作,為抗擊疫情提供更多力所能及的幫助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.